The Next Wave of ADC Development: From Precision Engineering to AI-Driven Insights

Dr. Kate Sasser is the Chief Scientific Officer of Tempus. Dr. Sasser brings over 20 years of experience in translational research and precision medicine in biological sciences across academia and the pharmaceutical and biotech industry. Prior to Tempus, she led the translational research, precision medicine, and R&D operations organizations within Genmab, a biotech company focused on developing transformative antibody therapeutics as medicine. She also led translational research for oncology at Johnson and Johnson (Janssen PRD), using translational and data science approaches to accelerate clinical development. Dr. Sasser graduated from Oregon State University with a BS in Microbiology, and received her PhD in integrated biomedical sciences from Ohio State University.

Razik Yousfi is the SVP and GM of AI Products at Tempus, where he leads multi-modal Foundation Model initiatives and the development of AI products for Life Sciences and clinical care. He previously served as CEO and CTO of Paige AI, a pioneer in AI for computational pathology, through its acquisition by Tempus in 2025. Razik is recognized for bridging deep technical expertise with executive leadership to deliver high-impact, AI-enabled solutions. A proponent of lean product development, he specializes in building and motivating cross-functional teams to solve complex problems. He is driven by a passion for creating customer-centric products at the intersection of data and AI—ultimately advancing a new generation of precision medicine tests that improve patient outcomes.

Dr. Gary Grad is an experienced medical oncologist who currently serves as Senior Medical Oncologist on medical affairs at Tempus. He has focused on delivering personalized precision cancer care and advancing treatment through innovative solutions. Dr. Grad has contributed significantly to the development of real-time, data-driven approaches to cancer treatment, leveraging AI and extensive clinical data. 

Dr. Martin Bontrager is a senior leader at Tempus, applying his Ph.D. and experience with real-world data to drive advancements in precision medicine. Dr. Bontrager's expertise lies in the harmonization of genomics and clinical data and developing technologies that enable rapid innovation in healthcare.